Biocon Cofounder Says US Tariffs Are Not a Problem for India

Biocon cofounder Kiran Mazumdar-Shaw stated that US tariffs are not an issue for India. She highlighted that India can help the US lower healthcare costs through cost-effective personalized medicine using artificial intelligence and gene therapies.

Addressing foreign investor pullout, Shaw noted that the Indian pharmaceutical sector is not overvalued. She also suggested exempting capital gains from taxes if investors reinvest their profits, helping keep capital within the country.